Literature DB >> 8282815

Interleukin-10 prevents spontaneous death of germinal center B cells by induction of the bcl-2 protein.

Y Levy1, J C Brouet.   

Abstract

In this study, we show that IL-10 enhances in vitro the viability of purified splenic B cells. There was a two- to threefold increase in recovery of viable cells during a 15-d culture period in the presence of IL-10. This effect was abolished by neutralizing antibodies to IL-10. The survival of large splenic B cells, which mostly represent follicular center cells, was similarly increased. The in vitro rescue from spontaneous death of the latter cells is known to involve a bcl-2-dependent pathway. We therefore investigated whether IL-10 might affect bcl-2 expression. Unseparated B cells as well as large splenic B cells displayed a strong expression of bcl-2 protein by immunofluorescence at days 2-7 of culture in the presence of IL-10. Other lymphokines such as IL-2 and IL-4 were able to trigger only a transient and faint expression of bcl-2; moreover, this effect was abolished by anti-IL-10 mAb. Inasmuch as activated B cells can produce their own IL-10, this lymphokine may play a crucial role in relieving from apoptosis those B cells that encounter their antigen in B cell follicles.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8282815      PMCID: PMC293803          DOI: 10.1172/JCI116977

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  27 in total

1.  Cytokine expression by germinal center cells.

Authors:  A W Butch; G H Chung; J W Hoffmann; M H Nahm
Journal:  J Immunol       Date:  1993-01-01       Impact factor: 5.422

2.  Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines.

Authors:  G Nuñez; L London; D Hockenbery; M Alexander; J P McKearn; S J Korsmeyer
Journal:  J Immunol       Date:  1990-05-01       Impact factor: 5.422

3.  Mechanism of antigen-driven selection in germinal centres.

Authors:  Y J Liu; D E Joshua; G T Williams; C A Smith; J Gordon; I C MacLennan
Journal:  Nature       Date:  1989 Dec 21-28       Impact factor: 49.962

4.  Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.

Authors:  F Pezzella; A G Tse; J L Cordell; K A Pulford; K C Gatter; D Y Mason
Journal:  Am J Pathol       Date:  1990-08       Impact factor: 4.307

5.  Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.

Authors:  D Hockenbery; G Nuñez; C Milliman; R D Schreiber; S J Korsmeyer
Journal:  Nature       Date:  1990-11-22       Impact factor: 49.962

6.  Deregulated Bcl-2-immunoglobulin transgene expands a resting but responsive immunoglobulin M and D-expressing B-cell population.

Authors:  T J McDonnell; G Nunez; F M Platt; D Hockenberry; L London; J P McKearn; S J Korsmeyer
Journal:  Mol Cell Biol       Date:  1990-05       Impact factor: 4.272

7.  The t(14;18) chromosome translocations involved in B-cell neoplasms result from mistakes in VDJ joining.

Authors:  Y Tsujimoto; J Gorham; J Cossman; E Jaffe; C M Croce
Journal:  Science       Date:  1985-09-27       Impact factor: 47.728

8.  bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation.

Authors:  T J McDonnell; N Deane; F M Platt; G Nunez; U Jaeger; J P McKearn; S J Korsmeyer
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

9.  Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.

Authors:  D F Fiorentino; M W Bond; T R Mosmann
Journal:  J Exp Med       Date:  1989-12-01       Impact factor: 14.307

10.  Epstein-Barr virus transformation induces B lymphocytes to produce human interleukin 10.

Authors:  N Burdin; C Péronne; J Banchereau; F Rousset
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more
  87 in total

1.  Interleukin 10 treatment for rheumatoid arthritis.

Authors:  E W St Clair
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors:  Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal:  Cell Mol Life Sci       Date:  2010-05-08       Impact factor: 9.261

3.  Resistance to cytotoxic chemotherapy is induced by NK cells in non-Hodgkin's Lymphoma Cells.

Authors:  Daeho Cho; Young-In Kim; Jae Seung Kang; Eunsil Hahm; Yoolhee Yang; Daejin Kim; Seonghan Kim; Yeong Seok Kim; Daeyoung Hur; Hyunjeong Park; Young Il Hwang; Tae-Sung Kim; Wang Jae Lee
Journal:  J Clin Immunol       Date:  2004-09       Impact factor: 8.317

Review 4.  Transcriptional reprogramming during T helper cell differentiation.

Authors:  T M Aune
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

5.  A network map of Interleukin-10 signaling pathway.

Authors:  Renu Verma; Lavanya Balakrishnan; Kusum Sharma; Aafaque Ahmad Khan; Jayshree Advani; Harsha Gowda; Srikanth Prasad Tripathy; Mrutyunjay Suar; Akhilesh Pandey; Sheetal Gandotra; T S Keshava Prasad; Subramanian Shankar
Journal:  J Cell Commun Signal       Date:  2015-08-08       Impact factor: 5.782

6.  Increased apoptosis of CD20+ IgA + B cells is the basis for IgA deficiency: the molecular mechanism for correction in vitro by IL-10 and CD40L.

Authors:  Zaheed Husain; Nichol Holodick; Caitlin Day; Irma Szymanski; Chester A Alper
Journal:  J Clin Immunol       Date:  2006-04-26       Impact factor: 8.317

Review 7.  T Follicular Regulatory Cells and Antibody Responses in Transplantation.

Authors:  Elizabeth F Wallin
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

8.  IL-2 and IL-7 but not IL-12 protect natural killer cells from death by apoptosis and up-regulate bcl-2 expression.

Authors:  M Armant; G Delespesse; M Sarfati
Journal:  Immunology       Date:  1995-06       Impact factor: 7.397

9.  Fas/Fas ligand (FasL)-deregulated apoptosis and IL-6 insensitivity in highly malignant myeloma cells.

Authors:  M A Frassanito; F Silvestris; N Silvestris; P Cafforio; G Camarda; G Iodice; F Dammacco
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

10.  Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis.

Authors:  B E Wilson; E Mochon; L M Boxer
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.